CClinicalTrials.gg
CompletedNCT03349047TOUCHUpdated Feb 21, 2019

Anxiety About Casual Exposure to Food Allergens

An interventional study of Behavioral intervention group and Education in Food Allergy, sponsored by Icahn School of Medicine at Mount Sinai. Completed at 1 site in United States. Open to participants aged 108 Months to 210 Months. Per ClinicalTrials.gov, last updated 2019-02-21.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
108 Months to 210 Months
Sex
All
01

Study summary

Living with food allergy may result in anxiety and reduced quality of life. Food allergic patients and their families are often concerned about casual exposure with the offending allergen through skin contact or being near the offending food, which is actually very low risk. This concern can limit social activities and increase stress. The aim of this study is to provide a behavioral intervention consisting of having peanut/tree nut allergic patients hold a cup with a peanut or tree nut to which the patient is allergic to and touching it. The goal is to reduce anxiety about casual exposure to food allergens and improve quality of life for patients with food allergies and their families.

Read the detailed description

The purpose of the present study is to determine if having patients (ages 9-17) who are peanut and/or tree nut allergic, and endorse anxiety/discomfort about non-ingestion exposure, hold and touch their offending allergen in addition to education leads to reduced discomfort for both patient and caregiver compared to education alone. The primary outcome measure is immediate differences in the score obtained on a child-reported scale in response to a question assessing how worried the patient is about the thought of being near or touching peanut or tree nut from pre-intervention to immediate post-intervention when compared between an intervention (education and touching) and a control group (education only). Secondary outcome measures include: difference between and within groups of child-reported scales regarding questions assessing patients worry regarding casual exposure immediately and one month post intervention within and between groups, differences between and within groups on a parent-reported scale regarding parental worry about casual exposure to food allergen immediately and one month post intervention within and between groups, differences between and within groups on a parent-proxy measures regarding child worry about casual exposure to food allergen immediately and one month post intervention within and between groups, improvement in child anxiety and parent-proxy measures of anxiety from pre-intervention to one month post-intervention within and between groups and improvement in parent-proxy measures of quality of life from pre-intervention to one month post-intervention within and between groups.

02

Conditions studied

  • Food Allergy

Keywords

  • Food Allergy
  • Anxiety
  • Casual Exposure
  • Peanut Hypersensitivity
  • Tree nut Hypersensitivity
  • Adolescents
03

Who can participate

Ages eligible
108 Months to 210 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age: 9 years to 17.5 years
  • Patient seen in the outpatient clinic (no inpatients).
  • Patient and or caretaker endorses anxiety about being in proximity with or touching peanut
  • Patients must have been diagnosed with a peanut and or tree nut allergy

Exclusion criteria

Exclusion Criteria:

  • Patients and caregiver(s) without ability to understand the study, as determined by either: a previously diagnosed cognitive disability or inability to repeat the study protocol at the time of consent.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Behavioral Intervention

    Behavioral Intervention Group - Education regarding nut allergy and will also have contact with nut.

    Behavioral: Behavioral intervention group · Behavioral: Education

  • Placebo comparator
    Control

    Education regarding nut allergy

    Behavioral: Education

Interventions

  • BehavioralBehavioral intervention group

    Patients will hold the peanut or tree nut in a cup and will be asked to touch the nut with their finger.

  • BehavioralEducation

    The group will be educated about what can occur with contact with or being in proximity of peanuts or tree nuts.

05

What researchers measure

Primary outcomes

  1. Child worry about casual exposure

    Change in a child-reported 10-point likert scale assessing how worried the child is about the thought of being near or touching peanut or tree nut, where 0 is not worried at all and 10 is extremely worried pre-intervention compared to immediately post-intervention.

    Time frame: Baseline and approximately 10 minutes

Secondary outcomes

  1. Parent worry about casual exposure

    Parent-proxy reported scale in response to additional questions assessing how worried the child is about the thought of being near or touching peanut or tree nut, where 0 is not worried at all and 10 is extremely worried, at one month compared to baseline.

    Time frame: Baseline and one month

  2. Food Allergy Quality of Life-Parental Burden (FAQL-PB) Questionnaire

    The score obtained on a parent-reported quality of life questionnaire (QOL). QOL is measured on a standardized FAQL-PB questionnaire which consists of 17 questions and responses are measured on a 6-point likert scale where 0 is not limited and 6 is very limited with total from 0 to 102.

    Time frame: One month

  3. The Screen for Child Anxiety Related Disorders (SCARED)

    Change in child anxiety at one month compared to baseline.The SCARED consists of 17 items, rated on a 3 point Likert-type scale. Total score range from 0 (not anxious) to 34 (very anxious).

    Time frame: Baseline and one month

  4. SCARED - parent version

    Change in parent-proxy measures of child anxiety on parent reported SCARED at one month compared to baseline. 17 items, rated on a 3 point Likert-type scale. Total score range from 0 (not anxious) to 34 (very anxious).

    Time frame: Baseline and one month

06

Study locations

1 site
  • Icahn School of Medicine at Mount Sinai
    New York, New York 10029, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03349047
Lead sponsor
Icahn School of Medicine at Mount Sinai
Responsible party
Sponsor
First posted
Nov 21, 2017
Start date
Nov 15, 2017
Primary completion
Jun 13, 2018
Completion
Jun 13, 2018
Last update
Feb 21, 2019

Study contacts

Scott Sicherer, MD
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion